Abrdn PLC Nkarta, Inc. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Abrdn PLC holds 28,988 shares of NKTX stock, worth $44,351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,988
Previous 28,988
-0.0%
Holding current value
$44,351
Previous $131,000
45.04%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$16.5 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$6.21 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$5.77 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$5.46 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$5.45 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $74.4M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...